CLINICAL_TRIALS
trial_result
· 2020-02-10
Clinical Trial Update: Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma [Phase 4]
Summary
Phase 4 neoadjuvant GM-CSF trial in cutaneous stage III/III melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Melanoma | Phase 4 | Status: COMPLETED | Results posted: 2020-02-10